Spinal L-type calcium channel blockade abolishes opioid-induced sensory hypersensitivity and antinociceptive tolerance

Anesthesia and Analgesia

Volumn 101, Issue 6, 2005, Pages 1730-1735

  Dogrul, Ahmet ^a   Bilsky, Edward J ^b   Ossipov, Michael H ^c   Lai, Josephine ^c   Porreca, Frank ^c,d  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b UNIVERSITY OF NEW ENGLAND   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; MORPHINE; OPIATE;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CROSS TOLERANCE; DRUG TOLERANCE; HOT PLATE TEST; HYPERALGESIA; HYPERESTHESIA; LATENT PERIOD; MALE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; TACTILE STIMULATION; TAIL FLICK TEST; THERMAL STIMULATION; WITHDRAWAL REFLEX;

EID: 28344441968     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000184253.49849.B0     Document Type: Article

References (25)

1. Foley KM. Opioids. Neurol Clin 1993;11:503-22.
2. White JM. Pleasure into pain: the consequences of long-term opioid use. Addict Behav 2004;29:1311-24.
3. Ossipov MH, Lai J, King T, et al. Antinociceptive and nociceptive actions of opioids. J Neurobiol 2004;61:126-48.
4. Doverty M, Somogyi AA, White JM, et al. Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain 2001;93:155-63.
5. Vanderah TW, Suenaga NM, Ossipov MH, et al. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci 2001;21:279-86.
6. Gardell LR, Wang R, Burgess SE, et al. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci 2002;22:6747-55.
7. Ossipov MH, Lai J, Vanderah TW, Porreca F. Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance. Life Sci 2003;73:783-800.
8. Gutstein HB, Rubie EA, Mansour A, et al. Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology 1997;87:1118-26.
9. Childers SR. Opioid receptor-coupled second messenger systems. Life Sci 1991;48:1991-2003.
10. Altier C, Zamponi GW. Targeting Ca2+ channels to treat pain: T-type versus N-type. Trends Pharmacol Sci 2004;25:465-70.
11. Dogrul A, Yesilyurt O, Deniz G, Isimer A. Analgesic effects of amlodipine and its interaction with morphine and ketorolac-induced analgesia. Gen Pharmacol 1997;29:839-45.
12. Dogrul A, Zagli U, Tulunay FC. The role of T-type calcium channels in morphine analgesia, development of antinociceptive tolerance and dependence to morphine, and morphine abstinence syndrome. Life Sci 2002;71:725-34.
13. Dogrul A, Yesilyurt O, Isimer A, Guzeldemir ME. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice. Pain 2001;93:61-8.
14. Porreca F, Burks TF. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse. J Pharmacol Exp Ther 1983;227:22-7.
15. Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994;53: 55-63.
16. Vanderah TW, Gardell LR, Burgess SE, et al. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 2000;20:7074-9.
17. Sjogren P, Jensen NH, Jensen TS. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists. Pain 1994;59:313-6.
18. Vanderah TW, Ossipov MH, Lai J, et al. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain 2001;92:5-9.
19. Yaksh TL, Harty GJ, Onofrio BM. High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology 1986;64:590-7.
20. Celerier E, Rivat C, Jun Y, et al. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 2000;92:465-72.
21. Tyler CB, Advokat C. Investigation of "cross-tolerance" between systemic and intrathecal morphine in rats. Physiol Behav 1986;37:27-32.
22. Roerig SC, O'Brien SM, Fujimoto JM, Wilcox GL. Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites. Brain Res 1984;308:360-3.
23. Vanegas H, Sensible H. Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia. Pain 2000;85:9-18.
24. Xie JY, Herman DS, Stiller CO, et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 2005;25: 409-16.
25. Welch SP, Olson KG. Opiate tolerance-induced modulation of free intracellular calcium in synaptosomes. Life Sci 1991;48: 1853-61.